1511 ET -- Merck & Co. is one of the most talked about companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Earlier Thursday, Merck said a West Virginia district court ruled in its favor in a two-patent infringement suit against Viatris Inc. regarding an ingredient in medication to treat type 2 diabetes. Also on Thursday, Merck said it agreed to buy Vence in a deal that would bolster the drugmaker's animal-health portfolio. Dow Jones & Co. owns Factiva. (susan.solan@wsj.com)

(END) Dow Jones Newswires

September 22, 2022 15:27 ET (19:27 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Merck Charts.